Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models - Wikidata - wikimedia - TriplyDB

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

http://www.wikidata.org/entity/Q36361515

about

One mouse, one patient paradigm: New avatars of personalized cancer therapy Targeting the RAS oncogene.Laboratory animal models for esophageal cancer Establishing a rabbit model of malignant esophagostenosis using the endoscopic implantation technique for studies on stent innovation The future of patient-derived tumor xenografts in cancer treatment.Individual patient oesophageal cancer 3D models for tailored treatment.Current status and perspectives of patient-derived xenograft models in cancer research.Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.An Integrative Analysis to Identify Driver Genes in Esophageal Squamous Cell Carcinoma Personalized targeted therapy for esophageal squamous cell carcinoma.Investigational therapies targeting the ErbB family in oesophagogastric cancer.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Downregulation of MLL3 in esophageal squamous cell carcinoma is required for the growth and metastasis of cancer cells.Phenotypic screening in the 21st century.Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization.Establishment and characterization of esophageal squamous cell carcinoma patient-derived xenograft mouse models for preclinical drug discovery.Aspirin acts in esophageal cancer: a brief review.Phase I dose-escalation trial of Sym004, an anti-EGFR antibody mixture, in Japanese patients with advanced solid tumors Tumor xenograft animal models for esophageal squamous cell carcinoma

P2860

Q27023342-C3EC9C8F-FA6B-4FD1-86FD-D3E1CD45294F Q27687198-EE65FE3E-D426-47F5-A7E3-F9FE7E4EFCA1 Q28069480-5084C1CE-99B9-4DFF-916D-C682C7FD02E9 Q30571618-CCA078EB-A0F2-4401-BA18-BED046DF1FCF Q33361578-0EC0970A-1273-4F4A-BDA5-E6AB43EBD8A5 Q33648440-510350CE-72CB-4CF3-9870-5D90BE234E21 Q33667686-9159616D-A685-4367-BBBE-15F1BDAD5057 Q35719104-7B6575E2-D4E2-4EA1-B924-ACC1BE1C747F Q35805987-0F0EABF2-BE07-4A2B-9DCD-30C760408398 Q35819517-DB578DD4-1966-426A-B002-A0A0CBE11FCF Q38221886-1E7C5A45-9DCE-41D9-B5D6-8AC05CDB2515 Q38729111-54A60730-A408-4350-A99B-ACD7696338C0 Q38951555-01447ACC-C3A4-4B6C-AE49-33767A32A469 Q42709072-815AF3DF-0B00-4F2E-8466-6C9B184CCBCC Q48164333-A7408940-4CAD-4E10-9B81-10F46E507B8C Q51512708-D743A36E-8C77-44B6-A299-035C095910EB Q55375453-EC717E20-297B-4C12-ADCD-4ECA4AAF6560 Q57652734-5EB4B43C-6FB2-4BD2-B4D2-9E33ED9FDFB9 Q58694943-DB19C146-A496-4075-A396-9308544D2035

P2860

Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models

http://www.wikidata.org/entity/Q36361515

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@ast

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@en

type

label

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@ast

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@en

prefLabel

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@ast

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@en

P1433

Q36361515-B9A01A7E-6D19-4116-85FF-8AEBC6029340

P1476

Q36361515-D5266A11-FDE4-4A34-A4C7-63539167EEA0

P2093

Q36361515-17BDC090-8D39-4B7B-B7C8-7D7B0192C911

Q36361515-27AC3F75-F9AF-4198-B303-464F0A8B7F11

Q36361515-2B9589DB-3224-4663-89C6-4F53A9842BEA

Q36361515-38A186AC-A98F-4085-9947-48D360CC95CC

Q36361515-3A27C48E-A475-46A5-96C6-B988018F2159

Q36361515-48F5E013-6033-4993-9C71-597BC010AA51

Q36361515-529FAC2C-D96D-4301-A1EF-3FE2FE95FC58

Q36361515-63C99510-12BE-4B17-A2E0-0F8566EBC7F1

Q36361515-8246017E-C625-40EC-8C80-120D841407AB

Q36361515-89FAE66F-0DD2-40AD-AA77-7CD6FB6C47F3

P2860

Q36361515-049329C4-63F2-4DDD-8C5C-8E4137DAC973

Q36361515-0913A623-4D74-4613-8039-F56BAB4D6998

Q36361515-13B7D22E-9D87-49A8-AB2F-C9CC46802018

Q36361515-156E80B6-F97B-4F3C-B0A1-185BB09CE163

Q36361515-187D8BB3-C39C-458B-BB61-3A28D4E2B62A

Q36361515-1A6C3FB1-57A3-45FC-BF14-2E8ECDFAFC0A

Q36361515-2461027E-301C-48AA-9C5B-522E3A88185A

Q36361515-2C388B79-142A-4150-A1CD-49CC615EDAB6

Q36361515-2DAB7645-EE9C-4A2E-8C5C-021775771A16

Q36361515-33DCBCDE-1718-4A69-B964-F4D0D0076157

P2888

Q36361515-98F729FD-2C32-4217-A3F1-EA7695909E68

P304

Q36361515-F1AF9C15-7A6B-48B2-9698-87B36C0C2A4A

P31

Q36361515-E0B6292F-DADA-4B75-A5DD-69E50888910B

P356

Q36361515-FAD18EB1-8725-487B-8367-A69E7FC47E4C

P478

Q36361515-5B71DFE9-0436-4F14-8C2A-FD64043F0C35

P577

Q36361515-AFF31E00-25DB-42A4-B43E-3BF94F7BAD8F

P5875

Q36361515-38C4F05D-C5BB-4328-AADC-256154352102

P6179

Q36361515-8B853171-74C0-4BD7-B8D5-759EAD24C8E7

P698

Q36361515-5092EC04-C8D3-4E42-9660-432D79F8319F

P921

Q36361515-032A21B2-3A38-4F38-AC39-C0431D1912D0

Q36361515-DC4B9577-66EF-4549-AC71-6B9B2BE7C61F

P932

Q36361515-0A180CA6-7B8F-40BA-ADCE-E9F2D94514EC

P356

1479-5876-10-180

P1433

Journal of Translational Medicine

P1476

Trastuzumab anti-tumor efficac ...... xenograft (PDECX) mouse models

@en

P2093

Chen Xu

http://www.w3.org/2001/XMLSchema#string

Deming He

http://www.w3.org/2001/XMLSchema#string

Di Ge

http://www.w3.org/2001/XMLSchema#string

Guanshan Zhu

http://www.w3.org/2001/XMLSchema#string

Jing Lv

http://www.w3.org/2001/XMLSchema#string

Jingchuan Zhang

http://www.w3.org/2001/XMLSchema#string

Jun Hou

http://www.w3.org/2001/XMLSchema#string

Li Zheng

http://www.w3.org/2001/XMLSchema#string

Liang Xie

http://www.w3.org/2001/XMLSchema#string

Paul R Gavine

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.

Cancer statistics, 2010

High frequency of mutations of the PIK3CA gene in human cancers

PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma

Oncogenic mutations of PIK3CA in human cancers

Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR

Trastuzumab--mechanism of action and use in clinical practice

P2888

1479-5876-10-180

P304

180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-10-180

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230768176

http://www.w3.org/2001/XMLSchema#string

P6179

1010421385

http://www.w3.org/2001/XMLSchema#string

P698

22935382

http://www.w3.org/2001/XMLSchema#string

P921

P932

3485623

http://www.w3.org/2001/XMLSchema#string